David Cushing

David Cushing is currently working as a Market Development Director and Remodulin Cardiopulmonary Specialist at United Therapeutics Corporation since February 2021. Prior to this role, David held positions at Insmed Incorporated and United Therapeutics focusing on promoting treatments for pulmonary arterial hypertension and MAC lung disease. With a background in biology, David also has experience in managed care, training, and sales management within the pharmaceutical industry. David holds a Master's Certificate in Health Care Ethics from Creighton University and a Bachelor of Science in Biology from Wayne State College.